Topp, E., Chapman, R., Devers-Lamrani, M., Hartmann, A., Marti, R., Martin-Laurent, F., et al. (2013). Accelerated Biodegradation of Veterinary Antibiotics in Agricultural Soil following Long-Term Exposure, and Isolation of a Sulfamethazine-degrading sp. J Environ Qual, 42(1), 173–178.
more information
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., et al. (2015). A new antibiotic kills pathogens without detectable resistance. Nature, 517(7535), 455–459.
more information
Spellberg, B., & Shlaes, D. (2014). Prioritized current unmet needs for antibacterial therapies. Clin Pharmacol Ther, 96(2), 151–153.
more information
Short, C. A., Cao, A. T., Wingfield, M. A., Doers, M. E., Jobe, E. M., Wang, N., et al. (2015). Subunit interfaces contribute differently to activation and allosteric modulation of neuronal nicotinic acetylcholine receptors. Neuropharmacology, 91, 157–168.
more information
Bertrand, D., & Gopalakrishnan, M. (2007). Allosteric modulation of nicotinic acetylcholine receptors. Biochem Pharmacol, 74(8), 1155–1163.
more information
Arias, H. R. (2010). Positive and negative modulation of nicotinic receptors. Adv Protein Chem Struct Biol, 80, 153–203.
more information
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009). Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev, 89(1), 73–120.
more information
Martin, L. F., Kem, W. R., & Freedman, R. (2004). Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl), 174(1), 54–64.
more information
Horti, A. G., Ravert, H. T., Gao, Y., Holt, D. P., Bunnelle, W. H., Schrimpf, M. R., et al. (2013). Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of alpha7-nicotinic acetylcholine receptors. Nucl Med Biol, 40(3), 395–402.
more information
Briggs, C. A., Gronlien, J. H., Curzon, P., Timmermann, D. B., Ween, H., Thorin-Hagene, K., et al. (2009). Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors. Br J Pharmacol, 158(6), 1486–1494.
more information